NCT05594797View on ClinicalTrials.gov

Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2027

Conditions
Multiple Myeloma
Interventions
DRUG

Human BCMA Targeted T Cells Injection

A single dose of predetermined level CAR-positive T cells will be infused.

Trial Locations (2)

200003

RECRUITING

Shanghai Changzheng Hospital, Shanghai

325000

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

Sponsors
All Listed Sponsors
collaborator

Shanghai Changzheng Hospital

OTHER

collaborator

First Affiliated Hospital of Wenzhou Medical University

OTHER

lead

Hrain Biotechnology Co., Ltd.

INDUSTRY